For PCOS patients who have failed ovulation induction therapy or may have other infertility issues that have not responded to conservative treatment – in vitro fertilization may be recommended. Extreme care, i.e., close monitoring and low doses of gonadotropin medications must be used. Again, PCOS patients are at high risk for ovarian hyperstimulation syndrome. The PCOS patient overall tends to produce a greater number of eggs than the non PCOS patient, but frequently eggs are of lower quality. If a PCOS patient has a very high response to gonadotropin stimulation frequently triggering (bring about the final maturation of the eggs) is done using a different medication, i.e., a short acting GnRH agonist, Lupron (instead of hCG). Dostinex medication prior to triggering final egg development has been shown to reduce the risks of ovarian hyperstimulation syndrome. If the PCOS patient’s estradiol and number of follicles is felt to be very excessive it is a good idea to either cancel the cycle or consider freezing all embryos as opposed to going ahead with a transfer. If the high response PCOS patient is pregnant, pregnancy itself continues to stimulate the ovary and can result in “late onset ovarian hyperstimulation syndrome”. There is evidence to suggest improved pregnancy rates with the addition of metformin to IVF cycles. For most PCOS patients once pregnancy is established metformin is discontinued. Metformin does not reduce the risk of miscarriage. If a PCOS patient is at significant risk for diabetes metformin may be continued.